Abadan, Rogen P.

HRN: 21-32-28  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/09/2022
05/15/2022
IV
500mg
Q6 Hours
Post CS
Waiting Final Action 
05/10/2022
CEFUROXIME 500MG (TAB)
05/10/2022
05/16/2022
ORAL
500mg/tab
BID
S/P Primary LTCS; EL; Appendectomy; Lavage
Waiting Final Action 
05/10/2022
METRONIDAZOLE 500MG (TAB)
05/10/2022
05/16/2022
ORAL
500mg/tab
TID
S/P Primary LTCS EL Appendectomy Lavage
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: